CAMBRIDGE NUTRITIONAL SCIENCES PLC

Report Publication Announcement • Aug 28, 2025

National Storage Mechanism | Additional information

RNS Number : 9111W

Cambridge Nutritional Sciences PLC

28 August 2025

Cambridge Nutritional Sciences plc

(the 'Company' or 'CNS')

Notice of AGM and Annual Report to 31 March 2025

CNSL (AIM: CNSL), the specialist medical diagnostics company focused on delivering a personalised approach to nutrition for better health, confirms that the Notice of Annual General Meeting ('AGM') has been finalised along with the Annual Report and Accounts for the year ended 31 March 2025. The Company's AGM will be held on Thursday 25 September 2025 at 3.00pm at E-space North, 181 Wisbech, Littleport, Ely, CB6 1RA.

The Annual Report will be posted to shareholders next week and will shortly be made available on the Company's website at:

https://www.cnsplc.com/financials/

Contacts:

Cambridge Nutritional Sciences PLC	www.cnsplc.com
James Cooper, Chief Executive Officer Ajay Patel, Chief Financial Officer	investors@cnsplc.com
Cavendish Capital Markets Limited	Tel: 020 7220 0500
Geoff Nash / Edward Whiley / (Corporate Finance)
Nigel Birks / Harriet Ward (Sales and ECM)

About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is the specialist medical diagnostics company focused on delivering a personalised approach to nutrition for better health.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOAEAAPXALSSEFA